Fundraising FoxTisentotx
2 known investors
Find your way into Tisentotx
Sign up to see every warm intro you have to Tisentotx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tisentotx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tisento develops pharmaceutical treatments for complex genetic mitochondrial diseases, beginning with MELAS. The company is led by a team of industry veterans focused on improving outcomes for patients with life-altering rare genetic conditions.
Founders & leadership
PH
Peter Hecht, PhDChief Executive Officer
PH
Peter HechtFounder
Investors · 2
Sanofi Ventures✓ confirmed by TisentotxCambridge · $5M
How we know: Sanofi Ventures's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Tisentotx do?
- Tisento develops pharmaceutical treatments for complex genetic mitochondrial diseases, beginning with MELAS. The company is led by a team of industry veterans focused on improving outcomes for patients with life-altering rare genetic conditions.
- Who are Tisentotx's investors?
- Tisentotx's investors include Sanofi Ventures, Venrock.